Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Mistletoe Extract in Superficial Bladder Cancer
2023-503718-66-00Phase 3Completed
- Sponsor
- ABNOBA GmbH
- Start
- Jun 2023
- Countries
- 2
01
Overview
Phase 3, randomised trial of abnobaVISCUM Fraxini in bladder cancer (2 arms), sponsored by ABNOBA GmbH. Primary endpoint: Time to tumor recurrence. Started Jun 2023; status: completed.
02
Drugs
abnobaVISCUM Fraxini
03
Conditions
bladder cancer
Beyond the preview
Go deeper on 2023-503718-66-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503718-66-00.